Metraipolis › archive › dc_de674c8ee6f7

Asparagine endopeptidase (AEP) inhibitor formulation via zein-based nanoparticle improves the therapeutic efficacy toward Alzheimer's disease — Europe PMC PMID:40816999

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40816999
DOI
10.1016/j.neurot.2025.e00718
License (as archived)
solo-consultazione
Archived
2026-11-10T15:03:41.410Z
SHA-256 of the archived text
a73a7f389796a1b14df010da20f9476c6b94b244d37f2d0d78a888019f3f59f2
Stable URL of this page
https://metraipolis.com/documento/dc_de674c8ee6f7

How to cite

Asparagine endopeptidase (AEP) inhibitor formulation via zein-based nanoparticle improves the therapeutic efficacy toward Alzheimer's disease — Europe PMC PMID:40816999 — Europe PMC (en), https://europepmc.org/article/MED/40816999 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de674c8ee6f7 (Metraipolis archive dc_de674c8ee6f7, sha256 a73a7f389796a1b14df010da20f9476c6b94b244d37f2d0d78a888019f3f59f2)
BibTeX
@misc{dcde674c8ee6f7,
  title = {Asparagine endopeptidase (AEP) inhibitor formulation via zein-based nanoparticle improves the therapeutic efficacy toward Alzheimer's disease — Europe PMC PMID:40816999},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40816999},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de674c8ee6f7; sha256 a73a7f389796a1b14df010da20f9476c6b94b244d37f2d0d78a888019f3f59f2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40816999. Agents can read the archived copy with the MCP tool read_document.